146 related articles for article (PubMed ID: 11740743)
1. High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment.
Bourreau E; Prévot G; Gardon J; Pradinaud R; Launois P
J Infect Dis; 2001 Dec; 184(12):1628-30. PubMed ID: 11740743
[TBL] [Abstract][Full Text] [Related]
2. In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment.
Bourreau E; Ronet C; Darsissac E; Lise MC; Marie DS; Clity E; Tacchini-Cottier F; Couppie P; Launois P
J Infect Dis; 2009 Feb; 199(4):576-9. PubMed ID: 19125672
[TBL] [Abstract][Full Text] [Related]
3. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
[TBL] [Abstract][Full Text] [Related]
4. Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica.
Kumar R; Bumb RA; Salotra P
FEMS Immunol Med Microbiol; 2009 Dec; 57(3):239-46. PubMed ID: 19799628
[TBL] [Abstract][Full Text] [Related]
5. Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana.
Nacher M; Carme B; Sainte Marie D; Couppié P; Clyti E; Guibert P; Pradinaud R
Ann Trop Med Parasitol; 2001 Jun; 95(4):331-6. PubMed ID: 11454242
[TBL] [Abstract][Full Text] [Related]
6. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: case of a patient with 425 lesions.
Couppié P; Clyti E; Sainte-Marie D; Dedet JP; Carme B; Pradinaud R
Am J Trop Med Hyg; 2004 Nov; 71(5):558-60. PubMed ID: 15569784
[TBL] [Abstract][Full Text] [Related]
7. Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure.
Christen JR; Bourreau E; Demar M; Lightburn E; Couppié P; Ginouvès M; Prévot G; Gangneux JP; Savini H; de Laval F; Pommier de Santi V; Briolant S
Travel Med Infect Dis; 2018; 24():31-36. PubMed ID: 29482012
[TBL] [Abstract][Full Text] [Related]
8. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis.
Bomfim G; Nascimento C; Costa J; Carvalho EM; Barral-Netto M; Barral A
Exp Parasitol; 1996 Nov; 84(2):188-94. PubMed ID: 8932768
[TBL] [Abstract][Full Text] [Related]
9. Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.
Ansari NA; Ramesh V; Salotra P
J Infect Dis; 2006 Oct; 194(7):958-65. PubMed ID: 16960784
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of short-course intramuscular pentamidine isethionate treatment on Old World localized cutaneous leishmaniasis in 2 patients.
Jauréguiberry S; Graby G; Caumes E
Clin Infect Dis; 2006 Jun; 42(12):1812-3. PubMed ID: 16705598
[No Abstract] [Full Text] [Related]
11. [Identification of Leishmania (V) guyanensis during recurrences of cutaneous leishmaniasis contracted in French Guyana].
Larriviere-Chouc C; De Pina JJ; Faraut-Gambarelli F; Morillon M; Normand P
Med Trop (Mars); 1996; 56(3):309. PubMed ID: 9026604
[No Abstract] [Full Text] [Related]
12. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
[TBL] [Abstract][Full Text] [Related]
13. [Management of cutaneous leishmaniasis in adults and children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2005 Nov; 65(5):487-95. PubMed ID: 16465821
[TBL] [Abstract][Full Text] [Related]
14. Monitoring the response of patients with cutaneous leishmaniasis to treatment with pentamidine isethionate by quantitative real-time PCR, and identification of Leishmania parasites not responding to therapy.
Mans DR; Kent AD; Hu RV; Lai A Fat EJ; Schoone GJ; Adams ER; Rood EJ; Alba S; Sabajo LO; Lai A Fat RF; de Vries HJ; Schallig HD
Clin Exp Dermatol; 2016 Aug; 41(6):610-5. PubMed ID: 26648589
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and tolerance of pentamidine for treatment of cutaneous leishmaniasis caused by por L. (V) panamensis in Colombia].
Robledo SM; Puerta JA; Muñoz DL; Guardo M; Vélez ID
Biomedica; 2006 Oct; 26 Suppl 1():188-93. PubMed ID: 17361854
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana.
Couppié P; Clyti E; Sobesky M; Bissuel F; Del Giudice P; Sainte-Marie D; Dedet JP; Carme B; Pradinaud R
Br J Dermatol; 2004 Dec; 151(6):1165-71. PubMed ID: 15606511
[TBL] [Abstract][Full Text] [Related]
17. Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy.
Lobo IM; Soares MB; Correia TM; de Freitas LA; Oliveira MI; Nakatani M; Netto E; Badaro R; David JR
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):642-9. PubMed ID: 16274713
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
19. Presence of Leishmania RNA Virus 1 in Leishmania guyanensis Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse.
Bourreau E; Ginouves M; Prévot G; Hartley MA; Gangneux JP; Robert-Gangneux F; Dufour J; Sainte-Marie D; Bertolotti A; Pratlong F; Martin R; Schütz F; Couppié P; Fasel N; Ronet C
J Infect Dis; 2016 Jan; 213(1):105-11. PubMed ID: 26123564
[TBL] [Abstract][Full Text] [Related]
20. Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.
Francesconi VA; Francesconi F; Ramasawmy R; Romero GAS; Alecrim MDGC
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006225. PubMed ID: 29481560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
